Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Immunohistochemical Markers
100%
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Immune Microenvironment
100%
SEPT9
100%
CXCR2
35%
Immunohistochemistry
21%
CD15
21%
CD68
14%
CD163
14%
Liver
7%
Tumor
7%
Cell Count
7%
Expression Level
7%
Immune Cells
7%
Clinical Utility
7%
Tumor Progression
7%
Clinical Parameters
7%
Survival Outcomes
7%
Tumor Formation
7%
Independent Prognostic Factor
7%
Pro-tumorigenic
7%
Hepatocellular Carcinoma Patients
7%
Oncogenic Proteins
7%
Immune Markers
7%
Immune Landscape
7%
Advanced Hepatocellular Carcinoma
7%
Clinical Survival
7%
Tumor Immune Microenvironment
7%
Medicine and Dentistry
Biological Marker
100%
Hepatocellular Carcinoma
100%
Septin
100%
Plasminogen Activator Inhibitor-1
100%
Interleukin 8 Receptor, Beta
35%
Immunohistochemistry
21%
Immunocompetent Cell
21%
Carcinogenesis
14%
Chlordane
14%
CD3 Antigen
14%
Neoplasm
7%
Cancer
7%
Tumor Progression
7%
Prognostic Factor
7%
Cell Count
7%
Cell Marker
7%
Tumor Immune Microenvironment
7%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Biological Marker
100%
Plasminogen Activator Inhibitor 1
100%
Septin
100%
Neoplasm
14%
Carcinogenesis
14%
Chlordane
14%
CD3 Antigen
14%
Tumor Growth
7%
Cell Marker
7%
Immunology and Microbiology
Immunocompetent Cell
100%
CD15
100%
CD68
66%
CD163
66%
CD3 Antigen
66%
Cell Count
33%
Cell Marker
33%